]>
IRCT2016080927995N2 IRCT 2016-11-26 Shahid Beheshti University of Medical Sciences Evaluating the impact of Halotherapy on improving pulmonary tests results and status of patients with Chronic Obstructive Pulmonary Disease referred to Dr. Masih Daneshvary hospital of Tehran in 2016 to 2017 Evaluating the impact of saturated steam with salt in improving pulmonary tests results and status of patients with Chronic Obstructive Pulmonary Disease attend in Dr. Masih Daneshvary hospital of Tehran in 1395 to 1396 2016-09-22 anticipated 84 Complete https://irct.ir/trial/22807 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Crossover, Purpose: Treatment. 3 Chronic obstructive pulmonary disease. Intervention 1: A kind of inhalation therapy with a mineral salt as an alternative treatment named halotherapy twice a day each for 30 minutes for 2-months. Intervention 2: Patients in control group use plastic contained Saltairs which have no inhaler in it actually as placebo drug.
public Alireza Eslaminejad
Masih Daneshvari Hospital, Daarabad, Niavaran, Tehran, Iran
Tehran Iran (Islamic Republic of) 1956944413 +98 21 2610 9647 eslaminejadalireza@yahoo.com Shahid Beheshti University of Medical Sciences scientific Alireza Eslaminejad
Masih Daneshvari Hospital, Daarabad, Niavaran, Tehran, Iran
Tehran Iran (Islamic Republic of) 1956944413 +98 21 2610 9647 eslaminejadalireza@yahoo.com Chronic Respiratory Diseases Research Center, NRITLD Iran (Islamic Republic of) Inclusion criteria: COPD patients regarding GOLD criteria; Stable patients older 18 years . Exclusion criteria: History of surgery in thorax; COPD exacerbation; Unbearable complications of COPD; Huge changes in treatment regimen; Missing patients through out the study; Irregular treatment; Smoking; Exacerbation in comorbidities like CHF, CRF, etc. 18 years 99 years Both J44.9 Chronic obstructive: airway disease NOS lung disease NOS Treatment - Drugs Placebo A kind of inhalation therapy with a mineral salt as an alternative treatment named halotherapy twice a day each for 30 minutes for 2-months Patients in control group use plastic contained Saltairs which have no inhaler in it actually as placebo drug. The walked distance. Timepoint: two month after first visit. Method of measurement: 6MWT. Forced vital capacity. Timepoint: two month after study beginning. Method of measurement: spirometry. Forced expiratory volume. Timepoint: two month after study beginning. Method of measurement: spirometry. Minute. Timepoint: 2 month after first visit. Method of measurement: 6MWD. Disease manifestation. Timepoint: 2 month after first visit. Method of measurement: Asking patients. Exacerbation rate. Timepoint: Every other month. Method of measurement: Asking patients. Shahid Beheshti University of Medical Sciences Approved 2011-06-26 Shahid Beheshti University of Medical Sciences Shahid Beheshti University of Medical Sciences, Yanan, Velenjak, Tehran Tehran Iran (Islamic Republic of)